Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 26, 2025
Misbehaving monocytes drive graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Leonard and Norma Klorfine Endowed Chair for Clinical Research awarded to Dr. Geoffrey Hill
Funding will help facilitate inter-institutional collaboration and foundational data capture for immunological research
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science
Gut microbes dictate donor T cell expansion and graft-versus-host disease risk after stem cell transplantation
From the Hill Lab, Translational Science and Therapeutics Division
Secret to tamping down GVHD may lie in microbial genetics
Preclinical bone marrow transplant study shows donor immune cells that target recipient microbiome can influence GVHD severity
The interplay between intestinal microbiota and graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
Something new and something old synergize to limit multiple myeloma relapse
From the Hill Lab, Translational Science and Therapeutics Division
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Dispatches from the microbial frontier of cancer research
Hutch scientists aim high by way of the lowly microorganisms that call us home
Thwarting relapse in patients with acute myeloid leukemia
From the Hill Lab, Clinical Research Division
A lasting impression: CMV exposure imprints donor T cell phenotypes
From the Hill Lab, Clinical Research Division
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Fred Hutch completes move-in of Lake Union Steam Plant
106,000-square-foot facility will be home to transformative data science and immunotherapy research aimed at faster cancer breakthroughs